{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:52:32Z","timestamp":1787932352260,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Qatar Research Development and Innovation Council","award":["ARG02-0402-240119"],"award-info":[{"award-number":["ARG02-0402-240119"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47216-z","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:27:28Z","timestamp":1776695248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of stroke following SARS-CoV-2 infection in a nationwide self-controlled case series study in qatar"],"prefix":"10.1038","volume":"16","author":[{"given":"Hiam","family":"Chemaitelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Al Jerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadat","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujatha","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Uy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Ben Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullatif","family":"Al-Khal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-Badi","family":"Abou-Samra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel A.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith J.","family":"Abu-Raddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"47216_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"Global burden of Disease Stroke Collaborators","year":"2021","unstructured":"Global burden of Disease Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 20, 795\u2013820. https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0 (2021).","journal-title":"Lancet Neurol."},{"key":"47216_CR2","unstructured":"United Nations. Transforming our world: The 2030 Agenda for Sustainable Development. (2023). Available from: https:\/\/sdgs.un.org\/2030agenda. Accessed on December 16, (2015)."},{"key":"47216_CR3","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMoa041747","volume":"351","author":"L Smeeth","year":"2004","unstructured":"Smeeth, L. et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 351, 2611\u20132618. https:\/\/doi.org\/10.1056\/NEJMoa041747 (2004).","journal-title":"N. Engl. J. Med."},{"key":"47216_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41586-024-08511-9","volume":"639","author":"H Chemaitelly","year":"2025","unstructured":"Chemaitelly, H. et al. Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron. Nature 639, 1024\u20131031. https:\/\/doi.org\/10.1038\/s41586-024-08511-9 (2025).","journal-title":"Nature"},{"key":"47216_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102102","volume":"62","author":"SH Qassim","year":"2023","unstructured":"Qassim, S. H. et al. Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: An observational study. EClinicalMedicine 62, 102102. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102102 (2023).","journal-title":"EClinicalMedicine"},{"key":"47216_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41591-022-01836-w","volume":"28","author":"L Subissi","year":"2022","unstructured":"Subissi, L. et al. An early warning system for emerging SARS-CoV-2 variants. Nat. Med. 28, 1110\u20131115. https:\/\/doi.org\/10.1038\/s41591-022-01836-w (2022).","journal-title":"Nat. Med."},{"key":"47216_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20118-6","volume":"12","author":"F Torabi","year":"2022","unstructured":"Torabi, F. et al. Risk of thrombocytopenic, haemorrhagic and thromboembolic disorders following COVID-19 vaccination and positive test: A self-controlled case series analysis in Wales. Sci. Rep. 12, 16406. https:\/\/doi.org\/10.1038\/s41598-022-20118-6 (2022).","journal-title":"Sci. Rep."},{"key":"47216_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1931","volume":"374","author":"J Hippisley-Cox","year":"2021","unstructured":"Hippisley-Cox, J. et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ 374, n1931. https:\/\/doi.org\/10.1136\/bmj.n1931 (2021).","journal-title":"BMJ"},{"key":"47216_CR9","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1212\/WNL.0000000000013184","volume":"98","author":"Q Yang","year":"2022","unstructured":"Yang, Q., Tong, X., George, M. G., Chang, A. & Merritt, R. K. COVID-19 and risk of acute ischemic stroke among Medicare beneficiaries aged 65 years or older: Self-controlled case series study. Neurology 98, e778\u2013e789. https:\/\/doi.org\/10.1212\/WNL.0000000000013184 (2022).","journal-title":"Neurology"},{"key":"47216_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","volume":"398","author":"I Katsoularis","year":"2021","unstructured":"Katsoularis, I., Fonseca-Rodriguez, O., Farrington, P., Lindmark, K. & Fors Connolly, A. M. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: A self-controlled case series and matched cohort study. Lancet 398, 599\u2013607. https:\/\/doi.org\/10.1016\/S0140-6736(21)00896-5 (2021).","journal-title":"Lancet"},{"key":"47216_CR11","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1161\/CIRCULATIONAHA.120.050809","volume":"142","author":"D Modin","year":"2020","unstructured":"Modin, D. et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation 142, 2080\u20132082. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050809 (2020).","journal-title":"Circulation"},{"key":"47216_CR12","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","volume":"27","author":"M Patone","year":"2021","unstructured":"Patone, M. et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat. Med. 27, 2144\u20132153. https:\/\/doi.org\/10.1038\/s41591-021-01556-7 (2021).","journal-title":"Nat. Med."},{"key":"47216_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/STROKEAHA.120.031786","volume":"52","author":"AI Qureshi","year":"2021","unstructured":"Qureshi, A. I. et al. Acute ischemic stroke and COVID-19: An analysis of 27 676 patients. Stroke 52, 905\u2013912. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031786 (2021).","journal-title":"Stroke"},{"key":"47216_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.brainresbull.2021.12.011","volume":"180","author":"Y Cui","year":"2022","unstructured":"Cui, Y. et al. Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis. Brain Res. Bull. 180, 31\u201337. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.12.011 (2022).","journal-title":"Brain Res. Bull."},{"key":"47216_CR15","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1161\/STROKEAHA.120.031217","volume":"51","author":"K Bekelis","year":"2020","unstructured":"Bekelis, K. et al. Ischemic stroke occurs less frequently in patients with COVID-19: A multicenter cross-sectional study. Stroke 51, 3570\u20133576. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031217 (2020).","journal-title":"Stroke"},{"key":"47216_CR16","doi-asserted-by":"publisher","first-page":"100716","DOI":"10.1016\/j.ijregi.2025.100716","volume":"16","author":"N Akhtar","year":"2025","unstructured":"Akhtar, N. et al. The association between previous SARS-CoV-2 infection and incidence of stroke. IJID Reg. 16, 100716. https:\/\/doi.org\/10.1016\/j.ijregi.2025.100716 (2025).","journal-title":"IJID Reg."},{"key":"47216_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47486-x","volume":"13","author":"N Ab Rahman","year":"2023","unstructured":"Ab Rahman, N. et al. Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: A self-controlled case series study. Sci. Rep. 13, 20471. https:\/\/doi.org\/10.1038\/s41598-023-47486-x (2023).","journal-title":"Sci. Rep."},{"key":"47216_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1198\/jasa.2011.ap10108","volume":"106","author":"CP Farrington","year":"2011","unstructured":"Farrington, C. P. et al. Self-controlled case series analysis with event-dependent observation periods. J. Am. Stat. Assoc. 106, 417\u2013426. https:\/\/doi.org\/10.1198\/jasa.2011.ap10108 (2011).","journal-title":"J. Am. Stat. Assoc."},{"key":"47216_CR19","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/sim.2302","volume":"25","author":"HJ Whitaker","year":"2006","unstructured":"Whitaker, H. J., Farrington, C. P., Spiessens, B. & Musonda, P. Tutorial in biostatistics: The self-controlled case series method. Stat. Med. 25, 1768\u20131797. https:\/\/doi.org\/10.1002\/sim.2302 (2006).","journal-title":"Stat. Med."},{"key":"47216_CR20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114114","volume":"385","author":"H Chemaitelly","year":"2021","unstructured":"Chemaitelly, H. et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N. Engl. J. Med. 385, e83. https:\/\/doi.org\/10.1056\/NEJMoa2114114 (2021).","journal-title":"N. Engl. J. Med."},{"key":"47216_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa2203965","volume":"387","author":"HN Altarawneh","year":"2022","unstructured":"Altarawneh, H. N. et al. Effects of previous infection and vaccination on symptomatic Omicron infections. N. Engl. J. Med. 387, 21\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2203965 (2022).","journal-title":"N. Engl. J. Med."},{"key":"47216_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taad106","author":"H Chemaitelly","year":"2023","unstructured":"Chemaitelly, H. et al. Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections. J Travel Med https:\/\/doi.org\/10.1093\/jtm\/taad106 (2023).","journal-title":"J Travel Med"},{"key":"47216_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270413","volume":"17","author":"N Akhtar","year":"2022","unstructured":"Akhtar, N. et al. Ischemic stroke in patients that recover from COVID-19: Comparisons to historical stroke prior to COVID-19 or stroke in patients with active COVID-19 infection. PLoS One 17, e0270413. https:\/\/doi.org\/10.1371\/journal.pone.0270413 (2022).","journal-title":"PLoS One"},{"key":"47216_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107095","volume":"145","author":"H Chemaitelly","year":"2024","unstructured":"Chemaitelly, H. et al. Association between COVID-19 vaccination and stroke: A nationwide case-control study in Qatar. Int. J. Infect. Dis. 145, 107095. https:\/\/doi.org\/10.1016\/j.ijid.2024.107095 (2024).","journal-title":"Int. J. Infect. Dis."},{"key":"47216_CR25","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1056\/NEJMoa2200797","volume":"386","author":"LJ Abu-Raddad","year":"2022","unstructured":"Abu-Raddad, L. J. et al. Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar. N. Engl. J. Med. 386, 1804\u20131816. https:\/\/doi.org\/10.1056\/NEJMoa2200797 (2022).","journal-title":"N. Engl. J. Med."},{"key":"47216_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2023.09.005","volume":"136","author":"H Chemaitelly","year":"2023","unstructured":"Chemaitelly, H. et al. Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: A national cohort study. Int. J. Infect. Dis. 136, 81\u201390. https:\/\/doi.org\/10.1016\/j.ijid.2023.09.005 (2023).","journal-title":"Int. J. Infect. Dis."},{"key":"47216_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1473-3099(23)00058-0","volume":"23","author":"H Chemaitelly","year":"2023","unstructured":"Chemaitelly, H. et al. Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: A retrospective population-based cohort study. Lancet Infect. Dis. 23, 816\u2013827. https:\/\/doi.org\/10.1016\/S1473-3099(23)00058-0 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"47216_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85428-7","volume":"11","author":"LJ Abu-Raddad","year":"2021","unstructured":"Abu-Raddad, L. J. et al. Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic. Sci. Rep. 11, 6233. https:\/\/doi.org\/10.1038\/s41598-021-85428-7 (2021).","journal-title":"Sci. Rep."},{"key":"47216_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012291","author":"AA AlNuaimi","year":"2023","unstructured":"AlNuaimi, A. A. et al. All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic. BMJ Glob Health https:\/\/doi.org\/10.1136\/bmjgh-2023-012291 (2023).","journal-title":"BMJ Glob Health"},{"key":"47216_CR30","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1002\/sim.9179","volume":"40","author":"O Fonseca-Rodriguez","year":"2021","unstructured":"Fonseca-Rodriguez, O., Fors Connolly, A. M., Katsoularis, I., Lindmark, K. & Farrington, P. Avoiding bias in self-controlled case series studies of coronavirus disease 2019. Stat. Med. 40, 6197\u20136208. https:\/\/doi.org\/10.1002\/sim.9179 (2021).","journal-title":"Stat. Med."},{"key":"47216_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4515","volume":"354","author":"I Petersen","year":"2016","unstructured":"Petersen, I., Douglas, I. & Whitaker, H. Self controlled case series methods: An alternative to standard epidemiological study designs. BMJ 354, i4515. https:\/\/doi.org\/10.1136\/bmj.i4515 (2016).","journal-title":"BMJ"},{"key":"47216_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1363045","volume":"11","author":"H Chemaitelly","year":"2024","unstructured":"Chemaitelly, H. et al. Addressing bias in the definition of SARS-CoV-2 reinfection: Implications for underestimation. Front. Med. 11, 1363045. https:\/\/doi.org\/10.3389\/fmed.2024.1363045 (2024).","journal-title":"Front. Med."},{"key":"47216_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/01632787211047932","volume":"44","author":"N Kojima","year":"2021","unstructured":"Kojima, N., Shrestha, N. K. & Klausner, J. D. A systematic review of the protective effect of prior SARS-CoV-2 infection on repeat infection. Eval. Health Prof. 44, 327\u2013332. https:\/\/doi.org\/10.1177\/01632787211047932 (2021).","journal-title":"Eval. Health Prof."},{"key":"47216_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2022.112911","volume":"209","author":"S Pilz","year":"2022","unstructured":"Pilz, S., Theiler-Schwetz, V., Trummer, C., Krause, R. & Ioannidis, J. P. A. SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity. Environ. Res. 209, 112911. https:\/\/doi.org\/10.1016\/j.envres.2022.112911 (2022).","journal-title":"Environ. Res."},{"key":"47216_CR35","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2024.1059","volume":"331","author":"Y Lu","year":"2024","unstructured":"Lu, Y. et al. Stroke risk after COVID-19 bivalent vaccination among US older adults. JAMA 331, 938\u2013950. https:\/\/doi.org\/10.1001\/jama.2024.1059 (2024).","journal-title":"JAMA"},{"key":"47216_CR36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda, N. et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N. Engl. J. Med. 385, 1078\u20131090. https:\/\/doi.org\/10.1056\/NEJMoa2110475 (2021).","journal-title":"N. Engl. J. Med."},{"key":"47216_CR37","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jama.2021.15072","volume":"326","author":"NP Klein","year":"2021","unstructured":"Klein, N. P. et al. Surveillance for adverse events after COVID-19 mRNA vaccination. JAMA 326, 1390\u20131399. https:\/\/doi.org\/10.1001\/jama.2021.15072 (2021).","journal-title":"JAMA"},{"key":"47216_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcm.2022.02.008","volume":"32","author":"T Iba","year":"2022","unstructured":"Iba, T. & Levy, J. H. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. Trends Cardiovasc. Med. 32, 249\u2013256. https:\/\/doi.org\/10.1016\/j.tcm.2022.02.008 (2022).","journal-title":"Trends Cardiovasc. Med."},{"key":"47216_CR39","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1161\/CIRCRESAHA.122.319954","volume":"130","author":"M De Michele","year":"2022","unstructured":"De Michele, M. et al. Cerebrovascular complications of COVID-19 and COVID-19 vaccination. Circ Res 130, 1187\u20131203. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.319954 (2022).","journal-title":"Circ Res"},{"key":"47216_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/pds.3337","volume":"22","author":"K Wilson","year":"2013","unstructured":"Wilson, K. & Hawken, S. Drug safety studies and measures of effect using the self-controlled case series design. Pharmacoepidemiol. Drug Saf. 22, 108\u2013110. https:\/\/doi.org\/10.1002\/pds.3337 (2013).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"47216_CR41","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1016\/j.csda.2012.04.017","volume":"56","author":"C Cox","year":"2012","unstructured":"Cox, C. & Li, X. Model-based estimation of the attributable risk: A loglinear approach. Comput. Stat. Data Anal. 56, 4180\u20134189. https:\/\/doi.org\/10.1016\/j.csda.2012.04.017 (2012).","journal-title":"Comput. Stat. Data Anal."},{"key":"47216_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/neurintsurg-2020-016794","volume":"13","author":"A Zakeri","year":"2021","unstructured":"Zakeri, A., Jadhav, A. P., Sullenger, B. A. & Nimjee, S. M. Ischemic stroke in COVID-19-positive patients: An overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J. Neurointerv. Surg. 13, 202\u2013206. https:\/\/doi.org\/10.1136\/neurintsurg-2020-016794 (2021).","journal-title":"J. Neurointerv. Surg."},{"key":"47216_CR43","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5 (2020).","journal-title":"Lancet"},{"key":"47216_CR44","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/STROKEAHA.120.032764","volume":"52","author":"N Kaneko","year":"2021","unstructured":"Kaneko, N. et al. Flow-mediated susceptibility and molecular response of cerebral endothelia to SARS-CoV-2 infection. Stroke 52, 260\u2013270. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032764 (2021).","journal-title":"Stroke"},{"key":"47216_CR45","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/14760584.2025.2596676","volume":"24","author":"H Chemaitelly","year":"2025","unstructured":"Chemaitelly, H. et al. Incidence of stroke following COVID-19 vaccination: A nationwide self\u2011controlled risk interval study in Qatar. Expert Rev. Vaccines 24, 1101\u20131110. https:\/\/doi.org\/10.1080\/14760584.2025.2596676 (2025).","journal-title":"Expert Rev. Vaccines"},{"key":"47216_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjph-2023-000479","volume":"1","author":"H Chemaitelly","year":"2023","unstructured":"Chemaitelly, H. Turning point in COVID-19 severity and fatality during the pandemic: A national cohort study in Qatar. BMJ Public Health 1, e000479. https:\/\/doi.org\/10.1136\/bmjph-2023-000479 (2023).","journal-title":"BMJ Public Health"},{"key":"47216_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter, N. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: A data linkage study. Lancet 399, 437\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(22)00017-4 (2022).","journal-title":"Lancet"},{"key":"47216_CR48","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.12.05032","volume":"12","author":"AA Butt","year":"2022","unstructured":"Butt, A. A. COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar. J. Glob. Health 12, 05032. https:\/\/doi.org\/10.7189\/jogh.12.05032 (2022).","journal-title":"J. Glob. Health"},{"key":"47216_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012328","author":"P Relan","year":"2023","unstructured":"Relan, P. et al. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis. BMJ Glob Health https:\/\/doi.org\/10.1136\/bmjgh-2023-012328 (2023).","journal-title":"BMJ Glob Health"},{"key":"47216_CR50","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMc2108120","volume":"385","author":"LJ Abu-Raddad","year":"2021","unstructured":"Abu-Raddad, L. J., Chemaitelly, H., Bertollini, R., National Study Group for Covid Epidemiology. Severity of SARS-CoV-2 reinfections as compared with primary infections. N. Engl. J. Med. 385, 2487\u20132489. https:\/\/doi.org\/10.1056\/NEJMc2108120 (2021).","journal-title":"N. Engl. J. Med."},{"key":"47216_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac109","author":"H Chemaitelly","year":"2022","unstructured":"Chemaitelly, H. et al. Duration of immune protection of SARS-CoV-2 natural infection against reinfection. J Travel Med https:\/\/doi.org\/10.1093\/jtm\/taac109 (2022).","journal-title":"J Travel Med"},{"key":"47216_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/biostatistics\/kxn013","volume":"10","author":"CP Farrington","year":"2009","unstructured":"Farrington, C. P., Whitaker, H. J. & Hocine, M. N. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 10, 3\u201316. https:\/\/doi.org\/10.1093\/biostatistics\/kxn013 (2009).","journal-title":"Biostatistics"},{"key":"47216_CR53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2307\/2533328","volume":"51","author":"CP Farrington","year":"1995","unstructured":"Farrington, C. P. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 51, 228\u2013235 (1995).","journal-title":"Biometrics"},{"key":"47216_CR54","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/oxfordjournals.aje.a008695","volume":"143","author":"CP Farrington","year":"1996","unstructured":"Farrington, C. P., Nash, J. & Miller, E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am. J. Epidemiol. 143, 1165\u20131173. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a008695 (1996).","journal-title":"Am. J. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47216-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47216-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47216-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:25:15Z","timestamp":1781648715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47216-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47216"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47216-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Butt has received institutional grant funding from Gilead Sciences unrelated to the work presented in this paper. Otherwise, we declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The institutional review boards at Hamad Medical Corporation and Weill Cornell Medicine\u2013Qatar approved this retrospective study with a waiver of informed consent. The study was conducted in accordance with the Declaration of Helsinki and reported following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"18297"}}